Nela Klein-González

622 total citations
13 papers, 344 citations indexed

About

Nela Klein-González is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Nela Klein-González has authored 13 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 9 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Nela Klein-González's work include Immunotherapy and Immune Responses (9 papers), CAR-T cell therapy research (8 papers) and T-cell and B-cell Immunology (4 papers). Nela Klein-González is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), CAR-T cell therapy research (8 papers) and T-cell and B-cell Immunology (4 papers). Nela Klein-González collaborates with scholars based in Germany, Spain and United States. Nela Klein-González's co-authors include Michael von Bergwelt‐Baildon, Andreas Draube, Corinne Brillant, Andreas Engert, Martin Hellmich, Manel Juan, Alexander Shimabukuro‐Vornhagen, Mireia Uribe‐Herranz, Luis Gerardo Rodríguez‐Lobato and Carlos Fernández de Larrea and has published in prestigious journals such as Blood, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Nela Klein-González

11 papers receiving 335 citations

Peers

Nela Klein-González
Tammy Maxwell Australia
Alfie T. Baker United Kingdom
Junko Ozao United States
Alexandra Cabanov United States
Helen Chae United States
Yun-Sun Kim South Korea
Nataliya Prokhnevska United States
Tammy Maxwell Australia
Nela Klein-González
Citations per year, relative to Nela Klein-González Nela Klein-González (= 1×) peers Tammy Maxwell

Countries citing papers authored by Nela Klein-González

Since Specialization
Citations

This map shows the geographic impact of Nela Klein-González's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nela Klein-González with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nela Klein-González more than expected).

Fields of papers citing papers by Nela Klein-González

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nela Klein-González. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nela Klein-González. The network helps show where Nela Klein-González may publish in the future.

Co-authorship network of co-authors of Nela Klein-González

This figure shows the co-authorship network connecting the top 25 collaborators of Nela Klein-González. A scholar is included among the top collaborators of Nela Klein-González based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nela Klein-González. Nela Klein-González is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Ortiz‐Maldonado, Valentín, Nela Klein-González, Eddie A. James, et al.. (2025). T-cell responses against CD19-targeted CAR T cells varnimcabtagene autoleucel (ARI-0001): implications for immune response and therapy outcomes. Journal for ImmunoTherapy of Cancer. 13(9). e010792–e010792.
2.
España, Carolina, Hugo Calderón, Lorena Pérez-Amill, et al.. (2025). A Quantitative Approach to Potency Testing for Chimeric Antigen Receptor-Encoding Lentiviral Vectors and Autologous CAR-T Cell Products, Using Flow Cytometry. Pharmaceutics. 17(3). 303–303.
3.
Pérez-Amill, Lorena, Álex Bataller, Julio Delgado, et al.. (2023). Advancing CART therapy for acute myeloid leukemia: recent breakthroughs and strategies for future development. Frontiers in Immunology. 14. 1260470–1260470. 13 indexed citations
4.
Uribe‐Herranz, Mireia, Nela Klein-González, Luis Gerardo Rodríguez‐Lobato, Manel Juan, & Carlos Fernández de Larrea. (2021). Gut Microbiota Influence in Hematological Malignancies: From Genesis to Cure. International Journal of Molecular Sciences. 22(3). 1026–1026. 49 indexed citations
5.
Wennhold, Kerstin, Nela Klein-González, Martin Thelen, et al.. (2016). CD40-activated B cells induce anti-tumor immunityin vivo. Oncotarget. 8(17). 27740–27753. 50 indexed citations
6.
Wennhold, Kerstin, Nela Klein-González, Michael von Bergwelt‐Baildon, & Alexander Shimabukuro‐Vornhagen. (2014). In Vitro and in Vivo Imaging of Initial T-B Cell Interactions in the Setting of B Cell-Based Cancer Immunotherapy. Blood. 124(21). 2740–2740. 2 indexed citations
7.
Draube, Andreas, Nela Klein-González, Corinne Brillant, et al.. (2011). Dendritic Cell Based Tumor Vaccination in Prostate and Renal Cell Cancer: A Systematic Review and Meta-Analysis. PLoS ONE. 6(4). e18801–e18801. 166 indexed citations
8.
Bergwelt‐Baildon, Michael S. von, Eisei Kondo, Nela Klein-González, & Clemens‐Martin Wendtner. (2011). The cyclins: a family of widely expressed tumor antigens?. Expert Review of Vaccines. 10(3). 389–395. 9 indexed citations
9.
Klein-González, Nela, et al.. (2010). Murine Model of CD40-activation of B cells. Journal of Visualized Experiments. 9 indexed citations
10.
Klein-González, Nela, et al.. (2010). Murine Model of CD40-activation of B cells. Journal of Visualized Experiments. 2 indexed citations
11.
Klein-González, Nela, Sandra Balkow, Eisaku Kondo, et al.. (2010). CD40-Activated B Cells Migrate Towards Secondary Lymphoid Organs And Interact Dynamically With T Cells. Biology of Blood and Marrow Transplantation. 16(2). S173–S174. 2 indexed citations
12.
Kondo, Eisei, Britta Maecker, Andreas Draube, et al.. (2009). The shared tumor associated antigen cyclin‐A2 is recognized by high‐avidity T‐cells. International Journal of Cancer. 125(10). 2474–2478. 5 indexed citations
13.
Kondo, Eisei, Nela Klein-González, Sebastian Rademacher, et al.. (2008). CD40-activated B cells can be generated in high number and purity in cancer patients: analysis of immunogenicity and homing potential. Clinical & Experimental Immunology. 155(2). 249–256. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026